Case Study: Regeneron Pharms., Inc. v. United States HHS

This case study focuses on the pharmaceutical company's challenge to a "Most Favored Nation" designation made by the Department of Health and Human Services, indirectly limiting the profits of the pharmaceutical company. Regeneron successfully argued that the government had failed to engage in appropriate rulemaking procedure.

The case can be found here:

https://law.justia.com/cases/federal/district-courts/new-york/nysdce/7:2020cv10488/550374/45/